Effects of finasteride on serum testosterone and body mass index in men with benign prostatic hyperplasiaROEHRBORN, Claus G; LEE, Michael; MEEHAN, Alan et al.Urology (Ridgewood, NJ). 2003, Vol 62, Num 5, pp 894-899, issn 0090-4295, 6 p.Article

Androgen antagonists : Potential role in prostate cancer preventionTRUMP, Donald L; WALDSTREICHER, Joanne A; KOLVENBAG, Geert et al.Urology (Ridgewood, NJ). 2001, Vol 57, Num 4A, pp 64-67, issn 0090-4295Article

Storage (irritative) and voiding (obstructive) symptoms as predictors of benign prostatic hyperplasia progression and related outcomesROEHRBORN, Claus G; MCCONNELL, John D; SALTZMAN, Brian et al.European urology. 2002, Vol 42, Num 1, pp 1-6, issn 0302-2838Article

Comparison of the efficacy and safety of finasteride in older versus younger men with benign prostatic hyperplasiaKAPLAN, Steven A; HOLTGREWE, H. Logan; MEEHAN, Alan et al.Urology (Ridgewood, NJ). 2001, Vol 57, Num 6, pp 1073-1077, issn 0090-4295Article

Sustained decrease in incidence of acute urinary retention and surgery with finasteride for 6 years in men with benign prostatic hyperplasiaROEHRBORN, Claus G; BRUSKEWITZ, Reginald; MEEHANT, Alan et al.The Journal of urology. 2004, Vol 171, Num 3, pp 1194-1198, issn 0022-5347, 5 p.Article

Incidence and severity of sexual adverse experiences in finasteride and placebo-treated men with benign prostatic hyperplasiaWESSELLS, Hunter; ROY, Johnny; PARRA, Raul et al.Urology (Ridgewood, NJ). 2003, Vol 61, Num 3, pp 579-584, issn 0090-4295, 6 p.Article

Long-term 6-year experience with finasteride in patients with benign prostatic hyperplasiaLOWE, Franklin C; MCCONNELL, John D; BRUSKEWITZ, Reginald C et al.Urology (Ridgewood, NJ). 2003, Vol 61, Num 4, pp 791-796, issn 0090-4295, 6 p.Article

Lowering low density lipoprotein cholesterol with simvastatin, a hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor, does not affect luteal function in premenopausal womenPLOTKIN, Diane; MILLER, Sam; SANTORO, Nanette et al.The Journal of clinical endocrinology and metabolism. 2002, Vol 87, Num 7, pp 3155-3161, issn 0021-972XArticle

The long-term effect of specific type II 5α-reductase inhibition with finasteride on bone mineral density in men: Results of a 4-year placebo controlled trialMATSUMOTO, Alvin M; TENOVER, Lisa; ZHANG, Gang K et al.The Journal of urology. 2002, Vol 167, Num 5, pp 2105-2108, issn 0022-5347Article

Lack of efficacy of finasteride in postmenopausal women with androgenetic alopeciaPRICE, Vera H; ROBERTS, Janet L; CULBERTSON, Jennifer et al.Journal of the American Academy of Dermatology. 2000, Vol 43, Num 5, pp 768-776, issn 0190-9622Article

Impact of baseline symptom severity on future risk of benign prostatic hyperplasia-related outcomes and long-term response to finasterideKAPLAN, Steven; GARVIN, Dennis; LEE, Michael et al.Urology (Ridgewood, NJ). 2000, Vol 56, Num 4, pp 610-616, issn 0090-4295Article